Stem cell therapy in knee medicine is evolving and potentially positive as a non-invasive treatment for osteoarthritis or cartilage injuries. When you consider the number of patients who are suffering ...
HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.
First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial
For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...
First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, ...
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...
An Osaka Metropolitan University team has used stem cells extracted from adipose, the body's fatty tissue, to treat spine ...
A lower number of CD26+ LSCs at diagnosis correlates with optimal molecular response in CML patients at 3, 12, and 24 months.
Progress has been made in identifying and treating the disease, but the impact of federal cuts is yet to be borne out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results